by In2Pharma | Aug 26, 2024 | News
Luxembourg The IML Code outlines the ethical standards that its members have committed to follow when promoting medicines to healthcare professionals (HCPs) and engaging with HCPs, healthcare organizations (HCOs), and patient organizations (POs). These guidelines...
by In2Pharma | May 11, 2023 | News
Luxembourg As previously announced, IML, the association of the innovative pharmaceutical industry in Luxembourg has revised and updated their Code of Ethics. The proposed amendments have been approved at the General Assembly held on 17 April 2023. The amounts of...
by In2Pharma | Mar 3, 2023 | News
Europe In January 2023 EMA published a new Q&A with a clarification of Day 0 in the context of local literature review when it concerns physical copies of journals. Marketing authorisation holders (MAH) must review and assess reports of suspected adverse...
by In2Pharma | Mar 1, 2023 | News
Luxembourg IML, the association of the innovative pharmaceutical industry in Luxembourg has revised and updated their Code of Ethics. The proposed amendments will be submitted for approval at the General Assembly to be held on 17 April 2023. Here below you can find a...
by In2Pharma | Feb 17, 2022 | News
Luxembourg APL, the Association Pharmaceutique Luxembourgeoise, is a Luxembourg-based association founded in 2011. The APL’s mission is to promote better healthcare by encouraging therapeutic innovation in the field of medicines for human use in Luxembourg. It...
